7.37. Analysis.
Comparison 7 Heterogeneity analyses, Outcome 37 Hypoglycemic events per 100 patient's days‐ number of basal doses (long acting).
Comparison 7 Heterogeneity analyses, Outcome 37 Hypoglycemic events per 100 patient's days‐ number of basal doses (long acting).